Antelopus Selan Energy Limited (ANTELOPUS)
Investor Presentation
Investor Presentation - Q2FY27
- Average sales volume 1656 boepd in Q2FY27 vs 1107 boepd in Q2FY26
- Revenue from operations (net) 119.1 Cr in Q2FY27 vs 55.1 Cr in Q2FY26
- EBITDA 90.0 Cr and net profit 57.3 Cr in Q2FY27
- Production growth target: onshore portfolio to reach 5000+ boepd by FY29
- Continuous drilling and capex in Cambay and KG Onland basins through FY27-FY29
- New DSF-IV licenses awarded, with 7 wells drilling by April 2027
- Cess refund of ~6.5 Cr recognized as other income in Q2FY27
- Bakrol and Karjisan fields delivering growth; KG Onland next growth leg
- Shared infrastructure and cluster development to accelerate production
- Management expects sustained production and EBITDA growth through FY29
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ANTELOPUS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ANTELOPUS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Antelopus Selan Energy Limited
Important.
The summary above is generated automatically from Antelopus Selan Energy Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.